Your Article Summary
Antigenics Announces a Negative Vote From the CHMP on Oncophage Marketing Application in Europe
Antigenics, 10/23/09
Antigenics Inc. announced that the Committee for Medicinal Products for Human Use, of the European Medicines Agency, has verbally informed the Company at an oral meeting to anticipate a negative opinion on the marketing authorization application for Oncophage in early–stage, localized renal cell carcinoma.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
Medtronic Introduces 3D Recon Service to Enhance Endovascular Treatment of Aortic Aneurysms
Medtronic, 11/20/09
Article Search
Sponsor


See Latest Articles


